A study comparing oral glucose-lowering agents to insulin for gestational diabetes found no non-inferiority in preventing ...

Oral glucose-lowering medications weren't up to snuff with insulin for gestational diabetes, a randomized clinical trial found. Among 820 individuals, 23.9% of infants born to mothers treated with a ...

The main variables in the protocols were duration of the study period (24 vs 48 weeks), dose of rituximab (500 vs 1000 mg), and number of cycles (1 vs 2). Hence, statistical analysis was conducted ...

The variables compared included dose (500 vs 1000 mg), duration of study (24 vs 48 weeks), and number of cycles (1 vs 2). They were statistically analyzed using the χ 2 test. There was a ...

Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...

Interested in an oral alternative to Ozempic injections? You might be considering metformin, an FDA-approved type 2 diabetes ...

A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...

Metformin, a widely prescribed medication for type 2 diabetes, may help protect individuals from the 2 most common types of ...

Metformin, an oral medication used to treat type 2 diabetes, is often prescribed off-label for weight loss. It helps to ...